Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Whitepaper: The Pharma R&D Annual Review 2019

Download now

Endometriosis affects an estimated one in 10 women

Find out more

Medtrack One Stop Shop Q&A Article Pack

Download now

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Generics Bulletin

New Formulations Of Old Ingredients Do Not Qualify For SPCs

By Aidan Fry 22 Mar 2019

Abraxis’ attempt to obtain a UK SPC for its Abraxane formulation of the known active ingredient paclitaxel has been thwarted by the CJEU.

Topic BioPharmaceutical

View article
Pink Sheet

Only One In Seven PRIME Applications Meet EMA Test

22 Mar 2019

Of the 14 applications for entry onto the European Medicines Agency’s priority medicines scheme during the first two months of 2019, only two – from AstraZeneca and Freeline – made the grade.

Topic Drug approval Drug development landscape Drug review

View article
Medtech Insight

Start-Up Spotlight: Innovative Cardiovascular Solutions Hopes To Win Regulatory Nod For Embolic Protector For TAVR

By Bob Kronemyer 22 Mar 2019

Transcatheter aortic valve replacement (TAVR) is performed routinely using devices providing protection from stroke as standard of care. However, cerebral embolic protection devices currently available do not capture and remove emboli from all three vessels leading to the brain. The Emblok Embolic Protection System from Innovative Cardiovascular Solutions (ICS) has developed an embolic filter designed to protect all three cerebral vessels during TAVR and remove debris from the entire circulatory system.

Topic Medtech

View article
Medtech Insight

Physicians Failing To Disclose Supplier, POD Arrangements Fuel Kickback Concerns, Senators Say

By Sue Darcey 22 Mar 2019

US Senate Finance Committee leaders say some physicians may have failed to disclose their physician-ownership interests in entities that offer medical supplies to the physician’s own practice, as required under the Physician Payment Sunshine Act. The legislators on March 19 prodded the Health and Human Services' Office of Inspector General (OIG) and the Centers for Medicare and Medicaid Services (CMS) to take a closer look into these arrangements.

Topic Business strategies Company analysis

View article
Scrip

India’s Top Court Tells Singhs To Come Up With Plan To Pay Daiichi, Uphold Nation’s ‘Honor’

By Penelope MacRae 22 Mar 2019

India’s Supreme Court has told Malvinder Singh and Shivinder Singh, once corporate billionaires, to work out a strategy within two weeks to pay Japanese drug giant Daiichi Sankyo a $500m arbitration award and "uphold the nation’s honor."

Topic Business strategies Deal trends

View article
Scrip

Price ‘Anchoring’? Zolgensma And The Art Of Managing Gene Therapy Sticker Shock

By Cathy Kelly 22 Mar 2019

Public statements by Novartis and Avexis suggest Zolgensma could be cost effective at a price up to $5m. Analysts expect $2m. The lower estimate is still stunning, but could it be considered reasonable by comparison?

Topic Drug review Drug approval

View article
Pharmaprojects

Pharma R&D Annual Review 2019

By Ian Lloyd 20 Mar 2019

Pharma R&D Annual Review 2019 is based on the stats and data from from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects.

Topic Clinical trials Diseases Research Drug approval Drug review

View white paper
Citeline, Pharmaprojects

Pharma R&D Annual Review 2019 whitepaper

By Ian Lloyd 20 Mar 2019

Welcome to Pharmaprojects’ 2019 review of trends in pharmaceutical R&D. For over a quarter of a century now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’ll look at the state of play at the start of 2019.

Topic Research Diseases

View white paper
Meddevicetracker

Meddevicetracker's Real-time Device Market Data API Solution

19 Mar 2019

Bringing our trusted data to your systems – fast.

Topic Medtech

View infographic
Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

12 Mar 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Topic Clinical trials Clinical trial optimization

Single report
Primal Pictures

Primal Pictures: 3D Functional Anatomy

12 Mar 2019

Engage, Educate and Inspire. Promote mastery of functional anatomy in any learning, teaching or practice environment – faster, easier and more efficiently than ever before.

View infographic
Pharmaprojects

Pharma R&D Annual Review 2019 Infographic

By Ian Lloyd 12 Mar 2019

Get your head in the game with a free download of the Pharma R&D Annual Review 2019 infographic from Informa Pharma Intelligence. This year’s look at the key players and reigning champs of R&D uses a sports theme to present its critical data on the current state of pharma R&D.

Topic Research Drug development landscape Diseases Drug review

View infographic
Meddevicetracker

Meddevicetracker API Infographic

11 Mar 2019

Quickly assess the competitive landscape, identify partnership opportunities, and spot threats before they become a problem with data from Meddevicetracker’s new API solution. The Real-time Device Market Data API from Meddevicetracker gives you the power to search and stream vital information directly from Meddevicetracker into your internal software systems and embed Meddevicetracker’s high-quality, exclusive datasets directly into your own workflows.

View infographic
HBW Insight

With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

By Malcolm Spicer 07 Mar 2019

Scott Gottlieb claimed higher profile than most previous FDA commissioners with frequent Twitter posts and by including his remarks in many agency communications to industries and consumers. In his nearly two years in post, he also had more central role in FDA initiatives in areas such as keeping unsafe products labeled as supplements off the market and explaining why hemp and CBD are available and supplements even though FDA considers the products noncompliant as dietary ingredients.

Topic FDA

View article
Medtech Insight

Drug-Coating Safety Risk Acknowledged At Cardiology Gathering, But Cause Remains Elusive

By Elizabeth Orr 07 Mar 2019

Physicians and researchers in an all-day session at the Cardiovascular Research Technologies conference in Washington, DC, on March 5 largely backed the recent finding that paclitaxel-coated balloons and stents may be tied to a higher patient mortality rate. But the specific mechanism underlying the deaths remains unknown.

Topic Medtech

View article

Latest headlines

Pink Sheet

26 Mar 2019

The Quality Lowdown: Diversion, Cross-Contamination And PR Mix-Ups

Link
Scrip

26 Mar 2019

Bluebird’s Gene Therapy LentiGlobin Coming Into Land In The EU?

Link
Medtech Insight

26 Mar 2019

EU Favors Italian Medtech Nomenclature Over GMDN For Revamped Eudamed

Link
Pink Sheet

26 Mar 2019

EU Project Seeks More Help To Improve Effectiveness Of Flu Vaccines

Link
Pink Sheet

25 Mar 2019

What Now After Brexit Delay? UK BioIndustry Association Asks

Link
Scrip

25 Mar 2019

AZ's Forxiga Gets Type 1 Diabetes EU Okay As Sanofi Suffers US Setback

Link
Pink Sheet

25 Mar 2019

EU Pharma Wants Staggered Approach For Direct Data Capture In Clinical Trials

Link
Medtech Insight

25 Mar 2019

Ibex Medical Raises $11M For AI-Based Pathology Tools

Link
Scrip

25 Mar 2019

Novartis’ Srinivasan On Putting Data Analytics To Use In Clinical Development

Link
Pink Sheet

25 Mar 2019

Oncology Sponsors Getting A Jump On Pediatric Study Requirements, US FDA Says

Link
Pink Sheet

25 Mar 2019

After 5-Year Winning Streak, Xarelto Makers Settle Personal Injury Suits

Link
Pink Sheet

25 Mar 2019

Pre-approval Promotion: Corporate Communications May Draw US FDA Scrutiny

Link
Scrip

25 Mar 2019

Allergan Acquiesces To Activist Appaloosa With CEO-Chairman Role Split, But Not Yet

Link
Scrip

25 Mar 2019

Pipeline Watch: Phase III Readouts For Vibegron, Doria And Ameluz

Link
In Vivo

25 Mar 2019

IXICO Targets Go-To Status In Neuro Data Analytics Space

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

Florida , USA

Industry conference

Experimental Biology

Spain

Industry conference

Global Regulatory Affairs Summit

Spain

Industry conference

eRegulatory Summit

View All Events

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Whitepaper: The Pharma R&D Annual Review 2019

Endometriosis affects an estimated one in 10 women

Medtrack One Stop Shop Q&A Article Pack

Welcome to your Pharma Intelligence advantage

Below are the Feature List

Market intelligence

News and insight

Data and analytics

Consultancy

Global industry experts

Trusted partnerships

Gold-standard service

Tailor-made solutions

Our Specialties

Pharma Intelligence latest insights

Latest headlines

Featured products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Upcoming events

Experimental Biology

Global Regulatory Affairs Summit

eRegulatory Summit

Keep up to date

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store